|
|
|
13.10.25 - 19:00
|
Börsenradio Schlussbericht Mo., 13.10.2025 - Trump, Zölle, KI und Gold: Nervosität mit Glanzmomenten - DAX leicht erholt (BRN)
|
|
|
Ratlosigkeit, Rallye, Rückzieher - die Märkte starten volatil in die neue Woche. Trumps 100-Prozent-Zölle auf China schockieren, dann rudert er zurück. Der DAX schließt bei 24.388 Punkten (+0,6 %), der MDAX bei 30.448 Punkten (+0,7 %). In den USA zieht der Dow Jones um 1 % an, die Nasdaq gewinnt 1,6 %. Broadcom sorgt mit einem KI-Deal mit OpenAI für Schlagzeilen: Künftig will der ChatGPT-Entwickler eigene Prozessoren mit Broadcom bauen - das macht Nvidia Konkurrenz. Die Aktie springt 6 % hoch. Gold erreicht mit 4.091 US-Dollar ein Rekordhoch, der Euro fällt auf 1,1571 US-Dollar. BMW und Fresenius Medical Care führen den DAX an, Bayer und Rheinmetall verlieren leicht. China reagiert gelassen, doch die Nervosität bleibt. Trump, Tweets, Taktik - das Muster wiederholt sich, und Anleger bleiben angespannt....
|
|
|
|
|
13.10.25 - 18:30
|
Navamedic ASA – New share capital registered (Cision)
|
|
|
Oslo, 13 October 2024: Reference is made to the stock exchange announcement published by Navamedic ASA (the "Company") on 7 October 2025, regarding the final result of the rights issue in the Company, where a total of 6,046,511 shares were allocated at a subscription price of NOK 21.50 per share, (the "Offer Shares") and the resolution to issue 272,090 new shares, at a subscription price of NOK 21.50 per share, (the "Underwriting Commission Shares") to the underwriters of the Rights issue as settlement of their entitlement to underwriting commission.
The share capital increases...
|
|
|
|
|
13.10.25 - 18:18
|
Repurchase of shares in Synsam during October 6, 2025 – October 10, 2025 (week 41) (Cision)
|
|
|
Synsam AB (publ) (LEI code: 5493000TMEGW9DHNOQ70) ("Synsam" or the "Company") has during October 6, 2025, to October 10, 2025, repurchased in total 100,000 own shares (ISIN code: SE0016829709) as part of the share buy-back program initiated by the board of directors of Synsam in order to adjust the Company's capital structure.
The repurchases form part of the share buy-back program of maximum MSEK 160 announced by Synsam on August 21, 2025, and which runs during the period from August 25, 2025, until February 27, 2026. The share buy-back program is being carried out in accordance with the EU...
|
|
|
|
|
|
|
|
|
|
|
|
|
13.10.25 - 17:48
|
Mauna Kea Technologies Reports Third Quarter 2025 Revenue Up +16% at Constant Exchange Rates (Business Wire)
|
|
|
U.S. sales surge +31% at constant exchange rates, with continued acceleration over the year
Commercial momentum highlighted by a doubling of U.S. system sales year-to-date
Adding to U.S. commercial team to support organic demandPARIS & BOSTON--(BUSINESS WIRE)--Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced its revenue for the third quarter of 2025, up 16% at constant exchange rates (CER).
Sacha Loiseau, Ph.D., Chairman and CEO of Mauna Kea Technologies, stated: “I am pleased with our significantly improved performance in the third quarter, reflecting the acceleration of our commercial momentum in the U.S., where we are benefiting from very positive clinical data presented earlier this year, strong support from a large group of leading physicians and attractive reimbursement. Responding to strengthening market demand, we have elected to expand our U.S. ...
|
|
|
13.10.25 - 17:48
|
Eurofins Scientific SE: Weekly Report on Share Repurchases from 06th October to 10th October 2025 (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer
Identify code of the Issuer
Transaction day
Identify code of the financial instrument
Total daily volume (in number of shares)
Daily weighted average purchase price of the shares
Market (MIC Code)
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
06/10/2025
FR0014000MR3
10 000
62.2576
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
07/10/2025
FR0014000MR3
10 000
62.1582
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
08/10/2025
FR0014000MR3
10 000
62.2099
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
09/10/2025
FR0014000MR3
10 000
62.6027
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
10/10/2025
FR0014000MR3
10 000
62.7664
XPAR
TOTAL
50 000
62.3990
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-progra...
|
|
|
|
|
|
|
13.10.25 - 17:01
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 47/2025
13 October 2025
Reykjavik, Iceland/Copenhagen, Denmark, 13 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 6 October to 10 October 2025 Embla Medical has acquired 75,000 shares under the Program at the average price of DKK 31.82. Following the transactions below, the Company holds 2,283,657 shares, corresponding to 0.53% of the...
|
|
|
|
|
|
|
|
|
|
|
13.10.25 - 15:36
|
Asklepios eröffnet neuen Logistik-Hub in Frankfurt am Main (News Aktuell)
|
|
|
Asklepios Kliniken GmbH & Co. KGaA: Hamburg/Frankfurt a. M. (ots) - - Neuer Logistik-Hub stärkt Versorgungssicherheit und Effizienz der Kliniken der Asklepios Gruppe in der Mitte und im Süden Deutschlands - Auch Einrichtungen von RHÖN und MEDICLIN sowie externe Einrichtungen werden ......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
